tiprankstipranks
Advertisement
Advertisement

TCRT Stock Latest News

Alaunos Therapeutics Faces Nasdaq Non-Compliance, Delisting Risk
Company AnnouncementsAlaunos Therapeutics Faces Nasdaq Non-Compliance, Delisting Risk
16d ago
8K
TCRT
Alaunos Reports Positive Preclinical Data for Obesity Candidate
PremiumCompany Announcements
Alaunos Reports Positive Preclinical Data for Obesity Candidate
2M ago
8K
TCRT
Alaunos Therapeutics reports ‘positive’ proof-of-concept data for ALN1003
PremiumThe Fly
Alaunos Therapeutics reports ‘positive’ proof-of-concept data for ALN1003
2M ago
TCRT
Alaunos Updates Governance, Ends Cantor Advisory Agreement
PremiumCompany Announcements
Alaunos Updates Governance, Ends Cantor Advisory Agreement
4M ago
8K
TCRT
Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer
PremiumCompany Announcements
Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer
4M ago
8K
TCRT
Alaunos Therapeutics files to sell 327,740 shares of common for holders
PremiumThe FlyAlaunos Therapeutics files to sell 327,740 shares of common for holders
6M ago
TCRT
Alaunos Therapeutics files $50M mixed securities shelf
Premium
The Fly
Alaunos Therapeutics files $50M mixed securities shelf
8M ago
TCRT
Alaunos Therapeutics Regains Nasdaq Compliance
Premium
Company Announcements
Alaunos Therapeutics Regains Nasdaq Compliance
8M ago
8K
TCRT
Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
PremiumCompany Announcements
Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
9M ago
TCRT
Alaunos Therapeutics’ Pediatric Brain Tumor Study Update: Implications and Insights
PremiumCompany Announcements
Alaunos Therapeutics’ Pediatric Brain Tumor Study Update: Implications and Insights
9M ago
TCRT
Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
PremiumCompany Announcements
Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
9M ago
TCRT
Alaunos Therapeutics’ TCR-T Study Update: Implications for Investors
PremiumCompany Announcements
Alaunos Therapeutics’ TCR-T Study Update: Implications for Investors
9M ago
TCRT
Alaunos Therapeutics Announces Departure of Melinda Lackey
PremiumCompany AnnouncementsAlaunos Therapeutics Announces Departure of Melinda Lackey
9M ago
8K
TCRT
Alaunos Therapeutics Holds Annual Stockholders Meeting
Premium
Company Announcements
Alaunos Therapeutics Holds Annual Stockholders Meeting
10M ago
8K
TCRT
Alaunos Therapeutics Appoints Holger Weis as New CEO
Premium
Company Announcements
Alaunos Therapeutics Appoints Holger Weis as New CEO
10M ago
8K
TCRT
Alaunos Therapeutics Raises $850,000 in Private Offering
PremiumCompany Announcements
Alaunos Therapeutics Raises $850,000 in Private Offering
10M ago
8K
TCRT
Alaunos Therapeutics Closes Registered Direct Offering
PremiumCompany Announcements
Alaunos Therapeutics Closes Registered Direct Offering
10M ago
8K
TCRT
Alaunos prices 610,399 shares at $3.36 in registered direct offering
PremiumThe Fly
Alaunos prices 610,399 shares at $3.36 in registered direct offering
10M ago
TCRT
Alaunos Therapeutics Amends Warrant Agreement with Mast Hill
PremiumCompany Announcements
Alaunos Therapeutics Amends Warrant Agreement with Mast Hill
11M ago
8K
TCRT
Alaunos Therapeutics Secures $25M Equity Purchase Deal
PremiumCompany AnnouncementsAlaunos Therapeutics Secures $25M Equity Purchase Deal
11M ago
8K
TCRT
PMGC Capital announces filing to report 5.09% stake in Alaunos Therapeutics
Premium
The Fly
PMGC Capital announces filing to report 5.09% stake in Alaunos Therapeutics
12M ago
ELAB
TCRT
Alaunos Therapeutics Board Opts for Equity Compensation
Premium
Company Announcements
Alaunos Therapeutics Board Opts for Equity Compensation
1y ago
8K
TCRT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >